Correlation Between Visa and BiondVax Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Visa and BiondVax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and BiondVax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and BiondVax Pharmaceuticals, you can compare the effects of market volatilities on Visa and BiondVax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of BiondVax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and BiondVax Pharmaceuticals.

Diversification Opportunities for Visa and BiondVax Pharmaceuticals

-0.94
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Visa and BiondVax is -0.94. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and BiondVax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BiondVax Pharmaceuticals and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with BiondVax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BiondVax Pharmaceuticals has no effect on the direction of Visa i.e., Visa and BiondVax Pharmaceuticals go up and down completely randomly.

Pair Corralation between Visa and BiondVax Pharmaceuticals

If you would invest  27,442  in Visa Class A on September 29, 2024 and sell it today you would earn a total of  4,424  from holding Visa Class A or generate 16.12% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy1.59%
ValuesDaily Returns

Visa Class A  vs.  BiondVax Pharmaceuticals

 Performance 
       Timeline  
Visa Class A 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Visa showed solid returns over the last few months and may actually be approaching a breakup point.
BiondVax Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BiondVax Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, BiondVax Pharmaceuticals is not utilizing all of its potentials. The recent stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Visa and BiondVax Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Visa and BiondVax Pharmaceuticals

The main advantage of trading using opposite Visa and BiondVax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, BiondVax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BiondVax Pharmaceuticals will offset losses from the drop in BiondVax Pharmaceuticals' long position.
The idea behind Visa Class A and BiondVax Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments